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Apical cytoskeleton can control the 
length of tubules
Readers of Kidney International know that the kidney, like many 
other epithelial organs, is composed of tubes whose segments 
vary in length and/or diameter. In the case of the lung, the 
diameter of the tubules is highly regulated and is likely to be 
genetically controlled. But in the kidney, where the diameter 
does not show such dramatic changes in ‘bore’ size (excluding 
the ureter), the length of the segments is quite variable; the 
proximal tubule is very long, hence convoluted, whereas some 
segments (connecting tubules and distal tubules) are much 
shorter. Even in the same kidney, the length of the loops of Henle 
varies signifi cantly between deep and superfi cial nephrons. 
Is there a mechanism for regulation of length? Studies on the 
branching morphogenesis of the fruit fl y trachea have recently 
identifi ed several mutations that cause the trachea to become 
long and convoluted. Th is tube has an  apical extracellular 
matrix (ECM) made of chitin, a highly complex N-acetyl 
glucosamine polymer that is converted to fi brils in the lumen 
by chitin-binding proteins. Chitin deacetylases are secreted 
and serve to modify the fi brils. Luschnig et al. knocked out two 
chitin-binding genes with deacetylase domains (vermiform and 
serpentine) and found that the trachea became excessively long 
and convoluted (Figure).1 When Wang et al. overexpressed two 
other luminal chitin deacetylase genes (ChLDs), they found that 
assembly of cable-like apical ECM was disturbed, which also 
resulted in aberrant tube elongation.2 Remarkably, the luminal 
deposition of these proteins required an intact septate junction. 
Separate junctions are the equivalent of the vertebrate tight 
junctions, though they are situated at the basal end of the lateral 
space. Th ese results suggest that the apical cytoskeleton can 
control the length of the tubule. Drosophila geneticists proposed 
that this might provide an explanation for cystic diseases of 
the kidney and elsewhere. Is there a relation here? Maybe the 
glycocalyx present on the apical surface of all epithelia is the 
equivalent of chitin ECM. But, regardless of the relevance of this 
to the kidney, the idea that one can change the length of a tube 
by removal of the internal cytoskeleton should be of interest to 
all epithelial-cell biologists. (1Curr Biol 2006; 16: 186–194. 2Curr 
Biol 2006; 16: 180–185)
Qais Al-Awqati
Bone marrow-derived cells 
improved Alport syndrome
Several reports have shown the ability of bone marrow (BM) 
cells to implant and diff erentiate into diff erent tissues, including 
the kidney. Sugimoto et al. showed that this property of BM 
cells can be put to use to repair renal damage, specifi cally, in 
an animal model of Alport syndrome. In Alport syndrome, 
mutations in glomerular basement membrane (GBM)-
associated type IV collagen genes (COL4A3, COL4A4, or 
COL4A5) lead to basement membrane structural defects, 
proteinuria, renal failure, and an absence of all three GBM 
The tracheal lumen is elongated and tortuous in serp verm mutants as 
compared with wild-type mice. 
Reprinted from Curr Biol, Vol. 16, Luschnig et al., “serpentine and vermiform encode 
matrix proteins with chitin binding and deacetylation domains that limit tracheal tube 
length in Drosophila,”  pp 186–194, with permission from Elsevier.
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About 10% of the resident glomerular cells in the transplanted 
COL4A3–/– are from the BM (shown here as wild-type BM-derived cells 
which are LacZ-positive).
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collagen triple helical chains because of obligatory post-
translational assembly requirements. Th e investigators 
showed that transplantation of wild-type BM into irradiated 
COL4A3–/– mice resulted in recruitment of BM-derived cells 
as epithelial cells (podocytes) and mesangial cells within the 
damaged glomerulus. Th is led to a partial restoration of type 
IV collagen α3 chain with concomitant emergence of α4 and 
α5 chain expression, improved glomerular architecture, and 
signifi cantly reduced proteinuria. Overall kidney histology also 
improved when compared with that of untreated COL4A3–/– 
mice or irradiated COL4A3–/– mice with BM cells from adult 
COL4A3–/– mice. Th e α3(IV) collagen produced by BM-
derived podocytes integrated into the GBM and associated 
with other α chains to form type IV collagen triple helical 
networks. Th is study demonstrates that BM-derived cells can 
off er a viable strategy for repairing basement membrane defects 
and conferring therapeutic benefi ts to patients with Alport 
syndrome. (Proc Natl Acad Sci USA 2006; 103: 7321–7326)
Juan Oliver
Procoagulant and vasoactive 
activities of erythropoietin
Recombinant human erythropoietin (rhEPO) is receiving 
increasing attention as a potential therapy for prevention of 
injury and restoration of function in nonhematopoietic tissues. 
However, the minimum eff ective dose required to mimic and 
augment these normal paracrine functions of erythropoietin 
in some organs (for example, the brain) is higher than that 
for treatment of anemia. Notably, a dose-dependent risk of 
adverse eff ects has been associated with rhEPO administration, 
especially in high-risk groups, including patients with 
polycythemia–hyperviscosity syndrome, hypertension, or 
vascular thrombosis. Several clinical trials using relatively high 
dosages of rhEPO in oncology patients were recently halted 
aft er an increase in mortality and morbidity, primarily because 
of thrombotic events. Coleman et al. recently identifi ed a 
heteromeric erythropoietin receptor complex that mediates 
tissue protection and is distinct from the homodimeric 
receptor responsible for the support of erythropoiesis. Th ey 
developed receptor-selective ligands that provide tools to 
assess which receptor isoform mediates which biological 
consequence of rhEPO therapy. Th en, they demonstrated that 
rhEPO administration in the rat increased systemic blood 
pressure, reduced regional renal blood fl ow, and increased 
platelet counts and procoagulant activities. In contrast, 
carbamylated rhEPO, a heteromeric receptor-specifi c ligand, 
increased renal blood fl ow, promoted sodium excretion, 
reduced injury-induced elevation in procoagulant activity, 
and did not eff ect platelet production. Th e authors suggest that 
non-erythropoietic tissue-protective ligands, which appear to 
elicit fewer adverse eff ects, may be especially useful in clinical 
settings for tissue protection. (Proc Natl Acad Sci USA 2006; 
103: 5965–5970)
Jai Radhakrishnan
Regulation of Wnt secretion
Development of complex multicellular organisms relies to large 
extent on the ability of cells to communicate via extracellular 
signals. By regulating cell-to-cell communication, the Wnt 
family of proteins plays multiple roles during embryogenesis of 
many organs. For example, both Wnt4 and Wnt9b have critical 
roles during renal development. In addition, recent evidence 
also implicates Wnt signaling in the postembryonic regulation 
of stem-cell number and diff erentiation in mammalian skin, 
colon epithelia, and the hematopoietic system. In addition, 
perturbations in Wnt signaling promote both human 
degenerative diseases and cancer. Because of the immense 
importance of this class of signaling proteins, there is a profound 
desire to understand how Wnt proteins are synthesized, 
transported, and received, and their signal transduced. In two 
recent communications, two independent laboratories describe 
a new membrane-associated protein (named Wntless by one 
group and Evi by the other) that is essential for Wnt signaling.1,2 
Working in Drosophila, the authors found that absence of 
Wntless/Evi resulted in phenotypes identical to those resulting 
from Wnt loss. Th ey also found that the cells that synthesize 
Wnts contained Wntless/Evi. Astonishingly, they observed that 
Wntless/Evi was required for action of all examined members 
of the Wnt family. Because loss of Wntless/Evi function has no 
eff ect on other signaling pathways, yet appears to impede all the 
Wnt signals analyzed, the authors proposed that Wntless/Evi 
represents an ancient partner for Wnts, dedicated to promoting 
their secretion into the extracellular milieu. Wntless/Evi 
function is evolutionarily conserved; disruption of its human 
homologue inhibited Wnt signaling in human cells. Th ese 
results open a novel avenue of research in a very important 
pathway for cell-to-cell communication. (1Cell 2006; 125: 
509–522. 2Cell 2006; 125: 523–533)
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wls is required for Wg-dependent patterning processes.
